VivoSim Labs, Inc. Research and Development Expense
VivoSim Labs, Inc. (VIVS) reported Research and Development Expense of $1.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-12
- VivoSim Labs, Inc. research and development expense for the quarter ending 2026-06-30 was $1.13M, a 13.09% increase year-over-year.
- VivoSim Labs, Inc. research and development expense for the quarter ending 2026-03-31 was $1.13M, a 30.97% increase year-over-year.
- VivoSim Labs, Inc. research and development expense for the quarter ending 2025-12-31 was $1.14M, a 35.96% decline year-over-year.
- VivoSim Labs, Inc. research and development expense for the quarter ending 2025-09-30 was $923.00K, a 6.20% decline year-over-year.
- VivoSim Labs, Inc. research and development expense for fiscal 2026 was $4.19M, a 16.64% decline from fiscal 2025.
- VivoSim Labs, Inc. research and development expense for fiscal 2025 was $5.03M, a 8.60% decline from fiscal 2024.
- VivoSim Labs, Inc. research and development expense for fiscal 2024 was $5.50M, a 38.12% decline from fiscal 2023.
- VivoSim Labs, Inc. research and development expense for fiscal 2023 was $8.88M, a 167.62% increase from fiscal 2022.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 59 month | Research and Development Expense 62 month | Research and Development Expense 65 month | Research and Development Expense 68 month | Research and Development Expense 71 month | Research and Development Expense 74 month | Research and Development Expense 77 month | Research and Development Expense 80 month | Research and Development Expense 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.13M 10-Q · filed 2026-08-12 | $2.26M derived: sum of 2 quarters · filed 2026-08-12 | $3.40M derived: sum of 3 quarters · filed 2026-08-12 | $4.32M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||||||
| 2026-03-31 | $1.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $2.27M derived: sum of 2 quarters · filed 2026-07-14 | $3.19M derived: sum of 3 quarters · filed 2026-07-14 | $4.19M 10-K · filed 2026-07-14 | ||||||||||||
| 2025-12-31 | $1.14M 10-Q · filed 2026-02-11 | $2.06M derived: sum of 2 quarters · filed 2026-02-11 | $3.06M 10-Q · filed 2026-02-11 | $3.92M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||||||
| 2025-09-30 | $923.00K 10-Q · filed 2025-11-06 | $1.92M 10-Q · filed 2025-11-06 | $2.78M derived: sum of 3 quarters · filed 2026-08-12 | $4.56M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||||||
| 2025-06-30 | $1.00M 10-Q · filed 2026-08-12 | $1.86M derived: sum of 2 quarters · filed 2026-08-12 | $3.64M derived: sum of 3 quarters · filed 2026-08-12 | $4.62M derived: sum of 4 quarters · filed 2026-08-12 | ||||||||||||
| 2025-03-31 | $859.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $2.64M derived: sum of 2 quarters · filed 2026-07-14 | $3.62M derived: sum of 3 quarters · filed 2026-07-14 | $5.03M 10-K · filed 2026-07-14 | ||||||||||||
| 2024-12-31 | $1.78M 10-Q · filed 2026-02-11 | $2.76M derived: sum of 2 quarters · filed 2026-02-11 | $4.17M 10-Q · filed 2026-02-11 | $5.23M derived: sum of 4 quarters · filed 2026-02-11 | ||||||||||||
| 2024-09-30 | $984.00K 10-Q · filed 2025-11-06 | $2.39M 10-Q · filed 2025-11-06 | $3.45M derived: sum of 3 quarters · filed 2025-11-06 | $4.88M derived: sum of 4 quarters · filed 2025-11-06 | ||||||||||||
| 2024-06-30 | $1.40M 10-Q · filed 2025-08-12 | $2.46M derived: sum of 2 quarters · filed 2025-08-12 | $3.90M derived: sum of 3 quarters · filed 2025-08-12 | $5.23M derived: sum of 4 quarters · filed 2025-08-12 | ||||||||||||
| 2024-03-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-05 | $2.50M derived: sum of 2 quarters · filed 2025-06-05 | $3.83M derived: sum of 3 quarters · filed 2025-06-05 | $5.50M 10-K · filed 2025-06-05 | ||||||||||||
| 2023-12-31 | $1.43M 10-Q · filed 2025-02-19 | $2.77M derived: sum of 2 quarters · filed 2025-02-19 | $4.43M 10-Q · filed 2025-02-19 | $9.88M derived: sum of 4 quarters · filed 2025-02-19 | ||||||||||||
| 2023-09-30 | $1.33M 10-Q · filed 2024-11-08 | $3.00M 10-Q · filed 2024-11-08 | $8.45M derived: sum of 3 quarters · filed 2024-11-08 | $9.63M derived: sum of 4 quarters · filed 2024-11-08 | ||||||||||||
| 2023-06-30 | $1.67M 10-Q · filed 2024-08-05 | $7.12M derived: sum of 2 quarters · filed 2024-08-05 | $8.30M derived: sum of 3 quarters · filed 2024-08-05 | $9.53M derived: sum of 4 quarters · filed 2024-08-05 | ||||||||||||
| 2023-03-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-31 | $6.63M derived: sum of 2 quarters · filed 2024-05-31 | $7.87M derived: sum of 3 quarters · filed 2024-05-31 | $8.88M 10-K · filed 2024-05-31 | ||||||||||||
| 2022-12-31 | $1.19M 10-Q · filed 2024-02-08 | $2.42M derived: sum of 2 quarters · filed 2024-02-08 | $3.44M 10-Q · filed 2024-02-08 | $4.57M derived: sum of 4 quarters · filed 2024-02-08 | ||||||||||||
| 2022-09-30 | $1.23M 10-Q · filed 2023-11-09 | $2.25M 10-Q · filed 2023-11-09 | $3.39M derived: sum of 3 quarters · filed 2023-11-09 | $4.31M derived: sum of 4 quarters · filed 2023-11-09 | ||||||||||||
| 2022-06-30 | $1.02M 10-Q · filed 2023-08-10 | $2.15M derived: sum of 2 quarters · filed 2023-08-10 | $3.08M derived: sum of 3 quarters · filed 2023-08-10 | $3.76M derived: sum of 4 quarters · filed 2023-08-10 | ||||||||||||
| 2022-03-31 | $1.14M derived: 10-K 12 month − 10-Q 9 month · filed 2023-07-14 | $2.06M derived: sum of 2 quarters · filed 2023-07-14 | $2.74M derived: sum of 3 quarters · filed 2023-07-14 | $3.32M 10-K · filed 2023-07-14 | ||||||||||||
| 2021-12-31 | $926.00K 10-Q · filed 2023-02-09 | $1.60M derived: sum of 2 quarters · filed 2023-02-09 | $2.19M 10-Q · filed 2023-02-09 | $2.86M derived: sum of 4 quarters · filed 2023-02-09 | ||||||||||||
| 2021-09-30 | $679.00K 10-Q · filed 2022-11-10 | $1.26M 10-Q · filed 2022-11-10 | $1.93M derived: sum of 3 quarters · filed 2022-11-10 | $2.33M derived: sum of 4 quarters · filed 2022-11-10 | ||||||||||||
| 2021-06-30 | $580.00K 10-Q · filed 2022-08-11 | $1.25M derived: sum of 2 quarters · filed 2022-08-11 | $1.66M derived: sum of 3 quarters · filed 2022-08-11 | $1.68M derived: sum of 4 quarters · filed 2022-08-11 | ||||||||||||
| 2021-03-31 | $673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-06-10 | $1.07M derived: sum of 2 quarters · filed 2022-06-10 | $1.10M derived: sum of 3 quarters · filed 2022-06-10 | $1.10M 10-K · filed 2022-06-10 | ||||||||||||
| 2020-12-31 | $402.00K 10-Q · filed 2022-02-14 | $430.00K derived: sum of 2 quarters · filed 2022-02-14 | $430.00K 10-Q · filed 2022-02-14 | $301.00K derived: sum of 4 quarters · filed 2022-02-14 | ||||||||||||
| 2020-09-30 | $28.00K 10-Q · filed 2021-11-08 | $28.00K 10-Q · filed 2021-11-08 | -$101.00K derived: sum of 3 quarters · filed 2021-11-08 | $44.00K derived: sum of 4 quarters · filed 2021-11-08 | ||||||||||||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-06 | -$129.00K derived: sum of 2 quarters · filed 2021-08-06 | $16.00K derived: sum of 3 quarters · filed 2021-08-06 | $1.46M derived: sum of 4 quarters · filed 2021-08-06 | ||||||||||||
| 2020-03-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-06-15 | $16.00K derived: sum of 2 quarters · filed 2021-06-15 | $1.46M derived: sum of 3 quarters · filed 2021-06-15 | $5.28M 10-K · filed 2021-06-15 | ||||||||||||
| 2019-12-31 | $145.00K 10-Q · filed 2021-02-08 | $1.59M derived: sum of 2 quarters · filed 2021-02-08 | $5.41M 10-Q · filed 2021-02-08 | $9.82M derived: sum of 4 quarters · filed 2021-02-08 | ||||||||||||
| 2019-09-30 | $1.45M 10-Q · filed 2020-11-05 | $5.27M 10-Q · filed 2020-11-05 | $9.67M derived: sum of 3 quarters · filed 2020-11-05 | $13.45M derived: sum of 4 quarters · filed 2020-11-05 | ||||||||||||
| 2019-06-30 | $3.82M 10-Q · filed 2020-08-10 | $8.23M derived: sum of 2 quarters · filed 2020-08-10 | $12.01M derived: sum of 3 quarters · filed 2020-08-10 | $15.20M derived: sum of 4 quarters · filed 2020-08-10 | ||||||||||||
| 2019-03-31 | $4.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-28 | $8.19M derived: sum of 2 quarters · filed 2020-05-28 | $11.37M derived: sum of 3 quarters · filed 2020-05-28 | $14.75M 10-K · filed 2020-05-28 | ||||||||||||
| 2018-12-31 | $3.78M 10-Q · filed 2020-02-10 | $6.97M derived: sum of 2 quarters · filed 2020-02-10 | $10.35M 10-Q · filed 2020-02-10 | $14.32M derived: sum of 4 quarters · filed 2020-02-10 | ||||||||||||
| 2018-09-30 | $3.19M 10-Q · filed 2019-11-07 | $6.57M 10-Q · filed 2019-11-07 | $10.54M derived: sum of 3 quarters · filed 2019-11-07 | $14.54M derived: sum of 4 quarters · filed 2019-11-07 | ||||||||||||
| 2018-06-30 | $3.38M 10-Q · filed 2019-08-08 | $7.35M derived: sum of 2 quarters · filed 2019-08-08 | $11.36M derived: sum of 3 quarters · filed 2019-08-08 | $16.30M derived: sum of 4 quarters · filed 2019-08-08 | ||||||||||||
| 2018-03-31 | $3.97M derived: 10-K 12 month − 10-Q 9 month · filed 2019-06-03 | $7.98M derived: sum of 2 quarters · filed 2019-06-03 | $12.92M derived: sum of 3 quarters · filed 2019-06-03 | $17.96M 10-K · filed 2019-06-03 | ||||||||||||
| 2017-12-31 | $4.00M 10-Q · filed 2019-02-07 | $8.95M derived: sum of 2 quarters · filed 2019-02-07 | $13.98M 10-Q · filed 2019-02-07 | $19.52M derived: sum of 4 quarters · filed 2019-02-07 | ||||||||||||
| 2017-09-30 | $4.94M 10-Q · filed 2018-11-08 | $9.98M 10-Q · filed 2018-11-08 | $15.51M derived: sum of 3 quarters · filed 2018-11-08 | $20.53M derived: sum of 4 quarters · filed 2018-11-08 | ||||||||||||
| 2017-06-30 | $5.03M 10-Q · filed 2018-08-09 | $10.57M derived: sum of 2 quarters · filed 2018-08-09 | $15.59M derived: sum of 3 quarters · filed 2018-08-09 | $20.13M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||||
| 2017-03-31 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $10.56M derived: sum of 2 quarters · filed 2018-05-31 | $15.10M derived: sum of 3 quarters · filed 2018-05-31 | $19.55M 10-K · filed 2018-05-31 | ||||||||||||
| 2016-12-31 | $5.02M 10-Q · filed 2018-02-08 | $9.57M derived: sum of 2 quarters · filed 2018-02-08 | $14.01M 10-Q · filed 2018-02-08 | $18.55M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||||
| 2016-09-30 | $4.54M 10-Q · filed 2017-11-09 | $8.99M 10-Q · filed 2017-11-09 | $13.53M derived: sum of 3 quarters · filed 2018-05-31 | $18.11M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||||
| 2016-06-30 | $4.44M 10-Q · filed 2017-08-09 | $8.98M derived: sum of 2 quarters · filed 2018-05-31 | $13.57M derived: sum of 3 quarters · filed 2018-05-31 | $18.31M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||||
| 2016-03-31 | $4.54M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $9.13M derived: sum of 2 quarters · filed 2018-05-31 | $13.87M derived: sum of 3 quarters · filed 2018-05-31 | $18.01M 10-K · filed 2018-05-31 | ||||||||||||
| 2015-12-31 | $4.59M 10-Q · filed 2017-02-09 | $9.32M derived: sum of 2 quarters · filed 2017-02-09 | $13.47M 10-Q · filed 2017-02-09 | $17.11M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||||
| 2015-09-30 | $4.74M 10-Q · filed 2016-11-03 | $8.88M 10-Q · filed 2016-11-03 | $12.52M derived: sum of 3 quarters · filed 2017-06-07 | $15.76M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||||
| 2015-06-30 | $4.14M 10-Q · filed 2016-08-04 | $7.78M derived: sum of 2 quarters · filed 2017-06-07 | $11.02M derived: sum of 3 quarters · filed 2017-06-07 | $14.25M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||||
| 2015-03-31 | $3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | $6.88M derived: sum of 2 quarters · filed 2017-06-07 | $10.11M derived: sum of 3 quarters · filed 2017-06-07 | $12.92M 10-K · filed 2017-06-07 | ||||||||||||
| 2014-12-31 | $3.24M 10-Q · filed 2016-02-08 | $6.47M derived: sum of 2 quarters · filed 2016-02-08 | $9.28M 10-Q · filed 2016-02-08 | $11.77M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||||
| 2014-09-30 | $3.23M 10-Q · filed 2015-11-09 | $6.04M 10-Q · filed 2015-11-09 | $8.53M derived: sum of 3 quarters · filed 2016-06-09 | $10.91M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||||
| 2014-06-30 | $2.81M 10-Q · filed 2015-08-10 | $5.30M derived: sum of 2 quarters · filed 2016-06-09 | $7.68M derived: sum of 3 quarters · filed 2016-06-09 | $9.30M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||||
| 2014-03-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | $4.87M derived: sum of 2 quarters · filed 2016-06-09 | $6.49M derived: sum of 3 quarters · filed 2016-06-09 | $7.97M 10-K · filed 2016-06-09 | $16.06M 10-K · filed 2014-06-10 | |||||||||||
| 2013-12-31 | $2.38M 10-Q · filed 2015-02-06 | $2.36M 10-Q · filed 2014-02-06 | $4.00M derived: sum of 2 quarters · filed 2015-02-06 | $5.49M 10-Q · filed 2015-02-06 | $5.42M 10-Q · filed 2014-02-06 | $6.93M derived: sum of 4 quarters · filed 2015-06-09 | $13.50M 10-Q · filed 2014-02-06 | |||||||||
| 2013-09-30 | $1.62M 10-Q · filed 2014-11-07 | $1.60M 10-Q · filed 2013-11-08 | $3.10M 10-Q · filed 2014-11-07 | $3.06M 10-Q · filed 2013-11-08 | $4.55M derived: sum of 3 quarters · filed 2015-06-09 | $5.68M derived: sum of 4 quarters · filed 2015-06-09 | $11.14M 10-Q · filed 2013-11-08 | |||||||||
| 2013-06-30 | $1.48M 10-Q · filed 2014-08-08 | $1.46M 10-Q · filed 2013-08-09 | $2.93M derived: sum of 2 quarters · filed 2015-06-09 | $4.06M derived: sum of 3 quarters · filed 2015-06-09 | $5.17M derived: sum of 4 quarters · filed 2015-06-09 | $9.54M 10-Q · filed 2013-08-09 | ||||||||||
| 2013-03-31 | $1.45M 10-K · filed 2015-06-09 | $2.58M derived: sum of 2 quarters · filed 2015-06-09 | $3.68M derived: sum of 3 quarters · filed 2015-06-09 | $4.34M derived: sum of 4 quarters · filed 2015-06-09 | $8.08M 10-KT · filed 2013-05-24 | |||||||||||
| 2012-12-31 | $1.13M 10-Q · filed 2014-02-06 | $2.24M derived: sum of 2 quarters · filed 2014-02-06 | $2.89M 10-Q · filed 2014-02-06 | $3.44M 10-K · filed 2015-06-09 | $6.63M 10-K · filed 2013-03-15 | |||||||||||
| 2012-09-30 | $1.11M 10-Q · filed 2013-11-08 | $1.11M 10-Q · filed 2012-11-14 | $1.76M 10-Q · filed 2013-11-08 | $2.31M 10-Q · filed 2012-11-14 | $2.71M derived: sum of 4 quarters · filed 2015-06-09 | $5.50M 10-Q · filed 2012-11-14 | ||||||||||
| 2012-06-30 | $653.00K 10-Q · filed 2013-08-09 | $652.57K 10-Q · filed 2012-08-14 | $1.20M 10-Q · filed 2012-08-14 | $1.61M derived: sum of 3 quarters · filed 2015-06-09 | $1.91M derived: sum of 4 quarters · filed 2015-06-09 | $4.40M 10-Q · filed 2012-08-14 | ||||||||||
| 2012-03-31 | $547.00K 10-K · filed 2015-06-09 | $547.29K 10-Q · filed 2012-05-15 | $953.02K derived: sum of 2 quarters · filed 2015-06-09 | $1.26M derived: sum of 3 quarters · filed 2015-06-09 | $1.57M derived: sum of 4 quarters · filed 2015-06-09 | $3.75M 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $406.02K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | $710.27K derived: sum of 2 quarters · filed 2014-06-10 | $1.02M derived: sum of 3 quarters · filed 2014-06-10 | $1.42M 10-K · filed 2014-06-10 | ||||||||||||
| 2011-09-30 | $304.25K 10-Q · filed 2012-11-14 | $615.32K derived: sum of 2 quarters · filed 2012-11-14 | $1.01M 10-Q · filed 2012-11-14 | |||||||||||||
| 2011-06-30 | $311.07K 10-Q · filed 2012-08-14 | $709.73K 10-Q · filed 2012-08-14 | ||||||||||||||
| 2011-03-31 | $398.66K 10-Q · filed 2012-05-15 | |||||||||||||||
| 2010-12-31 | $1.20M 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |